References
- Araujo AAS, Stropirtis S, Mercuri LP, Carvalho FMS, dos Santos Filho M, Matos JR. Thermal analysis of the antiretroviral Zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. International Journal of Pharmaceutics 2003; 260: 303–314
- Badri Viswanathan N, Thomas PA, Pandit JK, Kulkarni MG, Mashelkar RA. Preparation of non porous microspheres with high entrapment of proteins by a (water-in-oil)-in-oil emulsion technique. Journal of Controlled Release 1999; 58: 9–20
- Chow FPR, Hamburger AW. In vitro evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. European Journal of Hematology 1991; 47: 91–97
- Chowdary KPR, Koteshwara Rao N, Malathi K. Ethyl cellulose microspheres of glipizide: Characterization, in vitro and in vivo evaluation. Indian Journal of Pharmaceutical Sciences 2004; 66: 412–416
- Colson ER, Horwitz RI, Bia FJ, Viscoli CM. Zidovudine (AZT) for the treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. Archives of Internal Medicine 1991; 151: 709–713
- Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001; 13: 123–133
- Hayton WL, Chen T. Correction of perfusate concentration for sample removal. Journal of Pharmaceutical Sciences 1982; 71: 820–821
- Indian Pharmacopocia. 1996, Appendix 1.4.
- Klecker RW, Collins JM, Yarchan R, Thomas R, Jenkins JF, Broder S, Myers CS. Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clinical Pharmacology and Therapeutics 1987; 41: 407–412
- Lee J-H, Park TG, Choi H-K. Effect of formulation and processing variables on the characteristics of microspheres for water soluble drugs prepared by w/o/o double emulsion solvent diffusion method. International Journal of Pharmaceutics 2000; 196: 75–78
- Lutton JD, Mathew A, Levere RD, Abraham NG. Role of heme metabolism in AZT induced bone marrow toxicity. American Journal of Hematology 1990; 35: 1–5
- Mandal TK, Shekleton M, Onyebueke E, Washington L, Penson T. Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of Zidovudine. Journal of Microencapsulation 1996; 13: 545–557
- Mandal TK, Tenjarla S. Preparation of biodegradable microcapsules of Zidovudine using solvent evaporation: Effect of the modification of aqueous phase. International Journal of Pharmaceutics 1996; 137: 187–197
- Melzer E, Kreuter J, Daniels R. Ethyl cellulose: A new type of emulsion stabilizer. European Journal of Pharmaceutics and Biopharmaceutics 2003; 56: 23–27
- Narishetty STK, Panchagnula R. Transdermal delivery system for Zidovudine: in vitro ex vivo and in vivo evaluation. Biopharmaceutics and Drug Disposition 2004; 25: 9–20
- Richman DD, Fischl MA, Grieco MH, Gottlib MS, Voberding PA, Laskin OL, Leedom JM, Groopaman JE, Mildvan D, Hirsch MS, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. New England Journal of Medicine 1987; 317: 192–197
- Sprockel OL, Prapaitrakul W. A comparison of microencapsulation by various emulsion techniques. International Journal Pharmaceutics 1990; 58: 123–127
- Yamuda T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethyl cellulose and carboxymethylethylcellulose. Journal of Controlled Release 2001; 75: 271–282